Subscribe To
Cryptocurrency options trading explained
Cryptocurrency options trading explained Diving deep into the crypto asset landscape reveals a dynamic world of options contracts. On crypto exchange ...
October 24, 2023, 8:46 am
Why is ascent solar technologies (asti) stock up 51% today?
Ascent Solar Technologies (NASDAQ: ASTI ) stock is taking off on Tuesday following a funding recommendation from the Department of Energy (DOE). The ...
October 24, 2023, 8:10 am
Arbutus to report third quarter 2023 financial results and provide corporate update
WARMINSTER, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage...
October 24, 2023, 7:30 am
Avient corporation: long-term prospects remain encouraging despite risks
Revenues remain stagnant as the company has focused more on improved profitability. The company remains profitable despite recent margin volatility. I...
October 24, 2023, 2:16 am
L'oreal: encouraging growth across consumer products division
L'Oréal has seen strong growth in its Consumer Products division, with like-for-like sales increasing by 13.4% in Q3 2023. The division was boosted b...
October 23, 2023, 9:02 pm
Ambrx biopharma: potential with recently released prostate cancer data
Ambrx Biopharma Inc. updated data of ARX517 for the treatment of patients with mCRPC shows encouraging ...
October 23, 2023, 6:50 pm
Sirius real estate rating encouraging in current environment, says broker
Sirius Real Estate's continued receipt of a BBB rating from agency Fitch is encouraging especially i...
October 23, 2023, 10:01 am
Mastercard's masterstroke: leveraging ai to reduce payment problems
In the ever-evolving world of global payments, Mastercard isn't just going with the flow; they're orchestrating it with the power of AI. Mastercard an...
October 23, 2023, 9:25 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...
October 23, 2023, 5:00 am
Sutro biopharma announces presentation of data for luveltamab tazevibulin (luvelta) from the phase 1 dose-expansion study in endometrial cancers at esmo 2023
– Luvelta demonstrated encouraging preliminary anti-tumor activity (29% response rate) in late-stage ...
October 22, 2023, 8:25 am
Boyd gaming corporation: leveraging a digital expansion
Boyd Gaming's digital expansion taps into a burgeoning online casino market. Q3 earnings are expected to rise due to heightened summer vacation activi...
October 22, 2023, 4:02 am
Libtayo® (cemiplimab) neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma (cscc)
89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 tr...
October 21, 2023, 12:48 pm
Wolverine's (www) strategic growth efforts appear encouraging
Wolverine (WWW) has been progressing well on its strategic initiatives. The company also reinforces its presence in the international markets....
October 20, 2023, 1:32 pm
Steven madden's (shoo) strategic growth efforts progress well
Steven Madden's (SHOO) e-commerce business appears encouraging. The company has ramped up digital marke...
October 20, 2023, 1:32 pm
Csx ceo joe hinrichs on earnings and consumer: we're seeing 'encouraging' start to current quarter
Joe Hinrichs, CSX CEO, joins CNBC's "Squawk on the Street" to discuss the rail company's third-quarter earnings....
October 20, 2023, 11:20 am
Boe's bailey says expects a 'marked fall' in inflation next month
September inflation figures not far off what we were expectingCore inflation fell slightly from what we expected, that is quite encou...
October 20, 2023, 5:56 am